Fig. 2From: Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19The vital signs. O2 saturation percent in all patients of the control (A) and intervention (B) groups. Blood pressure measurement in control (C) and intervention (D) groups. Body temperature of control (E) and intervention (F) groups’ patients. Pulse rate of control (G) and intervention (H) groups’ patientsBack to article page